Telemark Asset Management, LLC Moderna, Inc. Transaction History

Telemark Asset Management, LLC

$858 Million
Q1 2024

A detailed history of Telemark Asset Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Telemark Asset Management, LLC holds 250,000 shares of MRNA stock, worth $29 Million. This represents 3.11% of its overall portfolio holdings.

Number of Shares

250,000

Holding current value

$29 Million

% of portfolio

3.11%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$85.37 - $115.44 $21.3 Million - $28.9 Million	250,000 New	250,000 $26.6 Million
Q2 2023 Aug 10, 2023	BUY	$118.5 - $160.53 $5.93 Million - $8.03 Million	50,000 Added 33.33%	200,000 $24.3 Million
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $20.3 Million - $29.6 Million	-150,000 Reduced 50.0%	150,000 $23 Million
Q4 2022 Feb 10, 2023	BUY	$118.38 - $210.04 $5.92 Million - $10.5 Million	50,000 Added 20.0%	300,000 $53.9 Million
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $7.08 Million - $11.7 Million	60,000 Added 31.58%	250,000 $29.6 Million

Q2 2022 Aug 11, 2022	SELL	$117.13 - $176.59 $1.17 Million - $1.77 Million	-10,000 Reduced 5.0%	190,000 $27.1 Million
Q1 2022 May 11, 2022	SELL	$126.46 - $235.05 $6.32 Million - $11.8 Million	-50,000 Reduced 20.0%	200,000 $34.5 Million
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $22.6 Million - $36.9 Million	-100,000 Reduced 28.57%	250,000 $63.5 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $11.1 Million - $24.2 Million	50,000 Added 16.67%	350,000 $135 Million
Q2 2021 Aug 10, 2021	BUY	$129.91 - $234.98 $8.44 Million - $15.3 Million	65,000 Added 27.66%	300,000 $70.5 Million
Q1 2021 May 12, 2021	BUY	$109.18 - $185.98 $25.7 Million - $43.7 Million	235,000 New	235,000 $30.8 Million

Others Institutions Holding MRNA

# of Institutions

1,040

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.36M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemark Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemark Asset Management, LLC with notifications on news.

Account

Telemark Asset Management, LLC Moderna, Inc. Transaction History